Bajovic 2012.
Methods | Randomised open‐label trial |
Participants | 182 patients with ICD‐10 criteria for alcohol dependence |
Interventions | (1) Oxcarbazepine, 51 participants; (2) topiramate, 42 participants; (3) lamotrigine, 49 participants; (4) symptomatic therapy, 40 participants Drug dose: oxcarbazepine 600 to 1200 mg/d; topiramate 100 to 200 mg/d); lamotrigine 75 to 200 mg/d Setting: inpatient and outpatient Duration: six months. Country of origin: Serbia |
Outcomes | Alcohol relapse; alcohol craving; side effects |
Notes | Conference proceedings |